{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T17:59:24Z","timestamp":1775152764436,"version":"3.50.1"},"reference-count":33,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2002,1,25]],"date-time":"2002-01-25T00:00:00Z","timestamp":1011916800000},"content-version":"vor","delay-in-days":24,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Investigation"],"published-print":{"date-parts":[[2002,1]]},"abstract":"<jats:p><jats:bold>Abstract<\/jats:bold><jats:bold> Background\u2002<\/jats:bold> A syndrome of lipodystrophy (LD) associated with peripheral lipoatrophy and central\/visceral adiposity has been reported in HIV\u20101\u2010infected patients treated by combined antiretroviral therapy (ART). Lipid metabolism is partly regulated by both steroid hormones and cytokines and we have previously reported that dyslipidaemia in LD\u2010positive men is correlated to an increase in cortisol\u00a0:\u00a0DHEA ratio (Christeff <jats:italic>et\u00a0al.<\/jats:italic>, <jats:italic>AIDS<\/jats:italic> 1999;13:2251). In this study we questioned whether it is also related to cytokine perturbations.<\/jats:p><jats:p><jats:bold>Materials and Methods\u2002<\/jats:bold> A cross\u2010sectional study was performed on 42 HIV\u20101\u2010positive men on ART, 27 of whom had symptoms of LD, defined by computed tomography scan. Serum cytokines (IFN\u2010\u03b1, TNF\u2010\u03b1, sTNF\u2010RI, sTNF\u2010RII, IL\u20106, IL\u20101\u03b2 and IL\u20102) and lipids [cholesterol, triglycerides (TG) and their subclasses], and apolipoproteins (Apo), were determined.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Serum IFN\u2010\u03b1 was markedly increased in LD\u2010positive compared with LD\u2010negative men and controls. IL\u20106 and TNF\u2010\u03b1 concentrations were also significantly elevated in HIV\u2010positive men compared to controls but the levels of these cytokines did not differ between the two groups of patients. A significant positive correlation was found between accumulation of IFN\u2010\u03b1 and increased levels of cholesterol, TG, VLDL cholesterol, VLDL TG, ApoB and ApoB\u2013ApoA1 ratio. A multivariate forward\u2010performed analysis revealed that IFN\u2010\u03b1 is the best marker for lipid perturbations associated to LD, followed by insulin and cortisol :\u00a0DHEA ratio.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> This study demonstrates an association between serum IFN\u2010\u03b1 and lipid alterations in LD\u2010positive men. The concomittant action of IFN\u2010\u03b1 and cortisol\u00a0:\u00a0DHEA ratio is probably one of the mechanisms responsible for hyperlipidaemia in LD syndrome.<\/jats:p>","DOI":"10.1046\/j.0014-2972.2001.00940.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T15:53:27Z","timestamp":1047398007000},"page":"43-50","source":"Crossref","is-referenced-by-count":40,"title":["Increased serum interferon alpha in HIV\u20131 associated lipodystrophy syndrome"],"prefix":"10.1111","volume":"32","author":[{"given":"N.","family":"Christeff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.\u2010C.","family":"Melchior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"De Truchis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Perronne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.\u2010L.","family":"Gougeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,1,25]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1086\/514638"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199807000-00003"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199911120-00007"},{"key":"e_1_2_6_5_2","first-page":"35","article-title":"Hyperlipidemia and insulin resisitance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection","volume":"23","author":"Mulligan K","year":"2000","journal-title":"J AIDS"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-127-10-199711150-00017"},{"key":"e_1_2_6_7_2","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/S0140-6736(05)78643-8","article-title":"Vascular complications associated with use of HIV protease inhibitors","volume":"351","author":"Gallet B","year":"1998","journal-title":"Lancet"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)00022-1"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.84.6.5740"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.74.5.1045"},{"key":"e_1_2_6_11_2","doi-asserted-by":"crossref","unstructured":"NunezEA ChristeffN.Steroid Hormones Cytokines Lipid and Metabolic Disturbances in HIV Infection. In:Norbiato G ed.The endocrinology and metabolism of HIV infection. London:1994 Bailliere\u2019s Clin Endocrinol Metab Bailli\u00e8re Tindall 8 803\u201324.","DOI":"10.1016\/S0950-351X(05)80302-7"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo-125-1-267"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo-127-1-46"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.76.3.559"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.83.21.8313"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2821621"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.79.4.1212"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1159\/000126396"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1080\/07435809609043788"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5728(86)90037-8"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910380222"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830201112"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1089\/jir.1998.18.125"},{"key":"e_1_2_6_24_2","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1182\/blood.V95.10.3191","article-title":"Alteration of TNFa+ T cell homeostasis following potent antiretroviral therapy. Contribution to the development of HIV\u2010associated lipodystrophy syndrome","volume":"95","author":"Ledru E","year":"2000","journal-title":"Blood"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(88)90576-1"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1991.03470100067035"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1998.tb09621.x"},{"key":"e_1_2_6_28_2","first-page":"196","article-title":"Serum cytokine changes in systemic vasculitis","volume":"68","author":"Grau GE","year":"1989","journal-title":"Immunolology"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.81.9.3265"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.50.4.341"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(88)80004-7"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.135.1.67"},{"key":"e_1_2_6_33_2","first-page":"E813","article-title":"Endocrine and metabolic effect of interleukin\u20106 in humans","volume":"31","author":"Stouthard JML","year":"1995","journal-title":"Am J Physiol"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-64-4-832"}],"container-title":["European Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.0014-2972.2001.00940.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.0014-2972.2001.00940.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.0014-2972.2001.00940.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T20:48:45Z","timestamp":1697575725000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.0014-2972.2001.00940.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,1]]}},"alternative-id":["10.1046\/j.0014-2972.2001.00940.x"],"URL":"https:\/\/doi.org\/10.1046\/j.0014-2972.2001.00940.x","archive":["Portico"],"relation":{},"ISSN":["0014-2972","1365-2362"],"issn-type":[{"value":"0014-2972","type":"print"},{"value":"1365-2362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,1]]}}}